The detection of HE4 and CA125 as the best performing early detection biomarkers for both endometrial and ovarian cancer is expected, given the presence of the endometrioid histotype in ovarian cancer and that both cancers are gynecological in nature. This evidence concerns the gene WFDC2 and ovarian cancer.